Sign In
to Vote &
Create Storyboards.
 
(Reuters) - Drugmaker AbbVie Inc said it will buy Pharmacyclics Inc , the maker of blockbuster cancer drug Imbruvica, for about $21 billion to boost its oncology drugs pipeline.
3
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard